| Title | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry |
| Abbreviation | Biochem. (Mosc.) Suppl. B: Biomed. Chem. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biochemistry (Q4); Clinical Biochemistry (Q4); Molecular Medicine (Q4) |
| h-index | 16 |
| Overall Rank/Ranking | 21846 |
| SCImago Journal Rank (SJR) | 0.168 |
| Impact Score | 0.59 |
| Publisher | Pleiades Publishing |
| Country | United States |
| ISSN | 19907516, 19907508 |
| Best Quartile | Q4 |
| Coverage History | 2007-2022 |
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is a journal covering the technologies/fields/categories related to Biochemistry (Q4); Clinical Biochemistry (Q4); Molecular Medicine (Q4). It is published by Pleiades Publishing. The overall rank of Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is 21846. According to SCImago Journal Rank (SJR), this journal is ranked 0.168. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 16. The best quartile for this journal is Q4.
The ISSN of Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry journal is 19907516, 19907508. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is cited by a total of 61 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is 0.59, which is computed in 2024 as per its definition. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry IF is decreased by a factor of 0.1 and approximate percentage change is -14.49% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is 0.59. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.59 |
| 2022 | 0.69 |
| 2021 | 0.43 |
| 2020 | 0.49 |
| 2019 | 0.63 |
| 2018 | 0.50 |
| 2017 | 0.44 |
| 2016 | 0.28 |
| 2015 | 0.35 |
| 2014 | 0.34 |
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry has an h-index of 16. It means 16 articles of this journal have more than 16 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is 19907516, 19907508. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is 21846. According to SCImago Journal Rank (SJR), this journal is ranked 0.168. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.168 |
| 2022 | 0.159 |
| 2021 | 0.143 |
| 2020 | 0.185 |
| 2019 | 0.200 |
| 2018 | 0.174 |
| 2017 | 0.160 |
| 2016 | 0.120 |
| 2015 | 0.129 |
| 2014 | 0.148 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 21846 |
| 2022 | 21365 |
| 2021 | 21533 |
| 2020 | 20336 |
| 2019 | 18469 |
| 2018 | 19476 |
| 2017 | 20126 |
| 2016 | 25244 |
| 2015 | 23270 |
| 2014 | 20780 |
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is published by Pleiades Publishing. It's publishing house is located in United States. Coverage history of this journal is as following: 2007-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is Biochem. (Mosc.) Suppl. B: Biomed. Chem.. This abbreviation ('Biochem. (Mosc.) Suppl. B: Biomed. Chem.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biochemistry (Q4); Clinical Biochemistry (Q4); Molecular Medicine (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry latest impact IF is 0.59. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 0.69 (2022) and 0.28 (2016), respectively, in the last 10 years. Moreover, its average IS is 0.47 in the previous 10 years.
The Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry has an SJR (SCImago Journal Rank) of 0.168, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.200 in 2019 and the lowest being 0.120 in 2016. Furthermore, the average SJR of the Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry over the previous 10-year period stands at 0.47.
The latest h-index of the Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is 16.
The Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is published by the Pleiades Publishing, with its country of publication being the United States.
The Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is currently ranked 21846 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 18469 in 2019 and its lowest position of 25244 in 2016.
The standard ISO4 abbreviation for the Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is Biochem. (Mosc.) Suppl. B: Biomed. Chem..
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is classified as a journal that the Pleiades Publishing publishes.
The Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is assigned the following International Standard Serial Numbers (ISSN): 19907516, 19907508.
The best quartile for the Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is Q4 (2023).
The Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry coverage history can be summarized as follows: 2007-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Field Archaeology | journal | 5619 | Maney Publishing | 45 | 1.64 |
| Clinical Medicine and Research | journal | 14722 | Marshfield Clinic | 62 | 1.02 |
| Current Sociology | journal | 7193 | SAGE Publications Ltd | 80 | 2.46 |
| Journal of Competition Law and Economics | journal | 10133 | Oxford University Press | 30 | 0.96 |
| Entrepreneurship Theory and Practice | journal | 220 | Wiley-Blackwell | 198 | 15.69 |
| Marine Biology Research | journal | 14120 | Taylor and Francis Ltd. | 45 | 1.02 |
| Transboundary and Emerging Diseases | journal | 5087 | 84 | 3.59 | |
| WSEAS Transactions on Environment and Development | journal | 20430 | World Scientific and Engineering Academy and Society | 25 | 0.92 |
| Revista de Metodos Cuantitativos para la Economia y la Empresa | journal | 22581 | Universidad Pablo de Olavide | 11 | 0.35 |
| Journal of Tropical Agriculture | journal | 22223 | Kerala Agricultural University | 19 | 0.25 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 0.59 |
| 2022 | 0.69 |
| 2021 | 0.43 |
| 2020 | 0.49 |
| 2019 | 0.63 |
| 2018 | 0.50 |
| 2017 | 0.44 |
| 2016 | 0.28 |
| 2015 | 0.35 |
| 2014 | 0.34 |
